Ironwood Investment Counsel LLC Has $612,000 Stock Holdings in Colgate-Palmolive (NYSE:CL)

Ironwood Investment Counsel LLC cut its stake in Colgate-Palmolive (NYSE:CL) by 3.6% during the fourth quarter, HoldingsChannel reports. The fund owned 6,727 shares of the company’s stock after selling 254 shares during the quarter. Ironwood Investment Counsel LLC’s holdings in Colgate-Palmolive were worth $612,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of CL. Kohmann Bosshard Financial Services LLC bought a new stake in Colgate-Palmolive during the fourth quarter valued at about $26,000. Centricity Wealth Management LLC bought a new stake in Colgate-Palmolive during the fourth quarter valued at about $27,000. Union Bancaire Privee UBP SA bought a new stake in Colgate-Palmolive during the fourth quarter valued at about $32,000. Briaud Financial Planning Inc bought a new stake in Colgate-Palmolive during the fourth quarter valued at about $32,000. Finally, Wintrust Investments LLC bought a new stake in Colgate-Palmolive during the fourth quarter valued at about $33,000. 80.41% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Friday. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the company an “overweight” rating in a report on Friday. TD Cowen reduced their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $101.72.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $89.80 on Friday. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The firm has a market capitalization of $72.87 billion, a PE ratio of 25.51, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The firm has a 50-day moving average price of $89.02 and a 200 day moving average price of $94.82.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the firm earned $0.87 earnings per share. Research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.